These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 17598505

  • 21. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F, Anger E, Baron V, Cartier I, Dorne H, Dubois-Gordeff A, Hassoun J, Jouannelle A, Labbé S, Locquet D, Marsan C, Martin E, Michiels-Marzias D, Molinié V, Mottot C, Mueller B, Vacher-Lavenu MC, Vincent S, Vuong PN.
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [Abstract] [Full Text] [Related]

  • 22. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG, Chew L, Wang SC.
    J Med Screen; 2006 Jul; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [Abstract] [Full Text] [Related]

  • 23. Human papillomavirus testing for primary cervical cancer screening.
    Grce M, Davies P.
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [Abstract] [Full Text] [Related]

  • 24. Current techniques in screening for cervical cancer in Spain: updated recommendations.
    Puig-Tintoré LM, Torné A, Alonso I.
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
    [Abstract] [Full Text] [Related]

  • 25. [Screening for prevention of cervical cancer in the Czech Republic].
    Tachezy R, Rob L.
    Cas Lek Cesk; 2007 Sep; 146(12):939-44. PubMed ID: 18257411
    [Abstract] [Full Text] [Related]

  • 26. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B, Morrell S, Zuo Y, Roder D, Tracey E, Jelfs P.
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [Abstract] [Full Text] [Related]

  • 27. Cervical cytology quality assurance in Washington State.
    Taylor V, Frost F.
    Acta Cytol; 1992 Aug; 36(2):246-50. PubMed ID: 1543009
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [Abstract] [Full Text] [Related]

  • 29. [Two cytological methods for screening for cervical cancer].
    Kirschner B, Simonsen K, Junge J.
    Ugeskr Laeger; 2008 May 26; 170(22):1933-7. PubMed ID: 18513478
    [Abstract] [Full Text] [Related]

  • 30. Liquid-based cytology can improve efficiency of cervical smear readers: evidence from timing surveys in two NHS cytology laboratories.
    Dowie R, Stoykova B, Crawford D, Desai M, Mather J, Morgan K, Shirt M.
    Cytopathology; 2006 Apr 26; 17(2):65-72. PubMed ID: 16548990
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL, Yen AM, Chen TH.
    J Med Screen; 2006 Apr 26; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A, Tayo A.
    J Obstet Gynaecol; 2007 Oct 26; 27(7):703-5. PubMed ID: 17999297
    [Abstract] [Full Text] [Related]

  • 33. Cervical cancer in Croatia: state of the art and possibilities for prevention.
    Znaor A, Strnad M.
    Coll Antropol; 2007 Apr 26; 31 Suppl 2():37-40. PubMed ID: 17598503
    [Abstract] [Full Text] [Related]

  • 34. [Cervical cancer screening: past--present--future].
    Breitenecker G.
    Pathologe; 2009 Dec 26; 30 Suppl 2():128-35. PubMed ID: 19756616
    [Abstract] [Full Text] [Related]

  • 35. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK, Nongkynrih B.
    Indian J Public Health; 2007 Dec 26; 51(4):216-21. PubMed ID: 18232160
    [Abstract] [Full Text] [Related]

  • 36. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
    Frable WJ.
    Arch Pathol Lab Med; 1997 Mar 26; 121(3):301-10. PubMed ID: 9111124
    [Abstract] [Full Text] [Related]

  • 37. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C, Austin RM.
    Cancer; 2008 Aug 25; 114(4):242-8. PubMed ID: 18484643
    [Abstract] [Full Text] [Related]

  • 38. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
    Sasagawa T.
    Rinsho Byori; 2009 Sep 25; 57(9):905-12. PubMed ID: 19860220
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.